Skip to content

Quadratus lumborum block versus transverse abdominal plane block for pain control after laparoscopic radical resection of colorectal cancer: a prospective, double-blind, randomized, controlled trial

Quadratus lumborum block versus transverse abdominal plane block for pain control after laparoscopic radical resection of colorectal cancer: a prospective, double-blind, randomized, controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032084
Enrollment
Unknown
Registered
2020-04-19
Start date
2020-04-25
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia in patients with colorectal cancer

Interventions

LQB group:local injection of ropivacaine
TAPB group:local injection of ropivacaine

Sponsors

Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 120 patients who underwent laparoscopic radical resection of colorectal cancer surgery were selected, regardless of gender, ASA grade I-II, aged 45-75 years, body mass index (BMI) 20-29 kg/?. 2. The informed consent of patients must be able to understand and are willing to participate in this study, and informed consent.

Exclusion criteria

Exclusion criteria: Severe cardiopulmonary and liver and kidney dysfunction, allergy to local anesthetics such as ropivacaine, puncture site infections, coagulopathy, mental disorders, neuropathic pain or chronic pain, other nerve blocks-related contraindications, refusing to accept regional block or other patients unable to cooperate treatment.

Design outcomes

Primary

MeasureTime frame
The activity and rest pain visual analogue (VAS) scores;the use of analgesics during operation;observations of vital signs;

Countries

China

Contacts

Public ContactLiuping Wu

Deparment of Anesthesiology, the Affiliated Hospital of Nantong University

1293193637@qq.com+86 18851311686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026